loadpatents
Patent applications and USPTO patent grants for ALB K; Nanna.The latest application filed is for "antisense oligomers targeting pcsk9".
Patent | Date |
---|---|
Antisense Oligomers Targeting Pcsk9 App 20220025376 - ALB K; Nanna ;   et al. | 2022-01-27 |
Antisense Oligomers Targeting Pcsk9 App 20200248186 - Kind Code | 2020-08-06 |
Antisense oligomers targeting PCSK9 Grant 10443058 - | 2019-10-15 |
Methods of treatment using antisense oligomers and conjugates targeting PCSK9 Grant 10385342 - | 2019-08-20 |
Manufacture of antisense oligomers and conjugates targeting PCSK9 Grant 10370668 - | 2019-08-06 |
Methods of Treatment Using Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312847 - ALB K; Nanna ;   et al. | 2018-11-01 |
Manufacture of Antisense Oligomers and Conjugates Targeting PCSK9 App 20180312846 - ALB K; Nanna ;   et al. | 2018-11-01 |
Oligonucleotide Conjugates App 20160138025 - ALB K; Nanna ;   et al. | 2016-05-19 |
Lna Oligonucleotide Carbohydrate Conjugates App 20150368642 - ALB K; Nanna ;   et al. | 2015-12-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.